Abstract The aim of this study was to assess the infectious diseases (ID) wards of tertiary hospitals in France and Turkey for technical capacity, infection control, characteristics of patients, infections, infecting organisms, and therapeutic approaches. This cross-sectional study was carried out on a single day on one of the weekdays of June 17-21, 2013. Overall, 36 ID departments from Turkey (n=21) and France (n=15) were involved. On the study day, 273 patients were hospitalized in Turkish and 324 patients were followed in French ID departments. The numbers of patients and beds in the hospitals, and presence of an intensive care unit (ICU) room in the ID ward was not different in both France and Turkey. Bed occupancy in the ID ward, single rooms, and negative pressure rooms were significantly higher in France. -014-2116-9 The presence of a laboratory inside the ID ward was more common in Turkish ID wards. The configuration of infection control committees, and their qualifications and surveillance types were quite similar in both countries. Although differences existed based on epidemiology, the distribution of infections were uniform on both sides. In Turkey, anti-Grampositive agents, carbapenems, and tigecycline, and in France, cephalosporins, penicillins, aminoglycosides, and metronidazole were more frequently preferred. Enteric Gram-negatives and hepatitis B and C were more frequent in Turkey, while human immunodeficiency virus (HIV) and streptococci were more common in France (p<0.05 for all significances). Various differences and similarities existed in France and Turkey in the ID wards. However, the current scene is that ID are managed with high standards in both countries.
The presence of a laboratory inside the ID ward was more common in Turkish ID wards. The configuration of infection control committees, and their qualifications and surveillance types were quite similar in both countries. Although differences existed based on epidemiology, the distribution of infections were uniform on both sides. In Turkey, anti-Grampositive agents, carbapenems, and tigecycline, and in France, cephalosporins, penicillins, aminoglycosides, and metronidazole were more frequently preferred. Enteric Gram-negatives and hepatitis B and C were more frequent in Turkey, while human immunodeficiency virus (HIV) and streptococci were more common in France (p<0.05 for all significances). Various differences and similarities existed in France and Turkey in the ID wards. However, the current scene is that ID are managed with high standards in both countries.
Introduction
France and Turkey are two large countries at the Mediterranean basin. The population of France, the largest country in the European Union, is around 66 million today (http://en.wikipedia.org/wiki/Demographics_of_France#cite_ note-metro-4). Turkey, located at the cross-section of three continents with close linkages to these geographical areas, has a population of 74 million according to 2010 data (http://en. wikipedia.org/wiki/Demographics_of_Turkey#cite_note-1). France is a developed country and has the world's seventh largest economy. On the other hand, Turkey is a strictly reorganizing country in the last 30 years and has the world's 15th largest economy (http://databank.worldbank.org/data/ download/GDP_PPP.pdf).
The infrastructures and technical capacities of infectious diseases (ID) departments, infection control (IC) and prevention organizations, epidemiology of infections, and antibiotic consumption habits have evolved according to their own historical experiences in both countries. The current designs for these issues are quite interrelated to lots of parameters, including healthcare systems, financial concepts, postgraduate training infrastructures, the epidemiology of infections and resistant pathogens, and the traditional medical point of views. Thus, this cross-sectional study was performed in both Turkey and France to disclose the ongoing ID practices in the ID wards, to delineate the effectiveness of their anti-infective management facilities, and to provide comparisons for these two large countries located at the opposite sides of Europe.
patients and ID departments were sent to participant centers. The first questionnaire evaluated the features of technical capacity of the ward and IC organization, along with characteristics of the ward personnel. The second questionnaire assessed the characteristics of patients, the quality of service provided, supportive care, characteristics of ID, infecting microorganisms, and treatment issues.
No data from military hospitals in both countries were enrolled. The cities where the participant centers were located are shown in Fig. 1 . On the study day, each hospitalized patient in the ID ward was visited by an ID specialist in each center. The data were inserted into separate MS Office Excel files, one related to the ID ward and the other for patient characteristics. The overall database was produced by merging the individual Excel files. SPSS 15.0 (SPSS Inc., Chicago, IL, USA) for Windows Evaluation Version was used for the statistical analysis. Descriptive statistics were presented as mean ± standard deviations, and frequency and percentage. Student's t-test was used to compare continuous variables. Pearson's chi-squared or Fisher's exact tests were used to compare categorical variables, as appropriate. A p-value of <0.05 was accepted as being statistically significant.
Results
Overall, 36 ID departments from Turkey (n=21) and France (n=15) were involved in this study. On the study day, 273 patients were hospitalized in Turkish and 324 patients were hospitalized in French ID departments. The mean age of the patients was 56.81±19.42 years. The mean duration of hospitalization for the patients in the study was 13 Table 1 .
Infection control and prevention
The procedures, quality standards, and requirements related to IC and prevention infrastructures in both countries were apparently comparable. However, both invasive device-related surveillance (21 of 21 centers vs. 10 of 15 centers) and surveillance of immunization for healthcare workers (HCWs) (20 of 21 centers vs. 10 of 15 centers) were performed significantly more frequently in Turkish hospitals (p<0.05 for both). The data related to IC are presented in Table 2 . Table 3 .
Antimicrobial therapy
On the study day, 215 (78.7 %) out of 273 patients and 251 (75.5 %) out of 324 patients were given antibiotics in Turkey and France, respectively (p 0.705). French ID specialists preferred to use antibiotics based on cultures and Table 4 .
Distribution of etiological agents
The etiological agent was confirmed microbiologically in 147 patients in Turkey and in 214 patients in France. The infecting organisms are presented in Table 5 .
Discussion
In this study, the participant hospitals were quite similar and comparable in France and Turkey according to their patients and bed capacities. The presence of an intensive care unit (ICU) room and room oxygenation systems were apparently similar in the ID wards in both countries. Nevertheless, the presence of negative pressure rooms, which are used to prevent cross-contaminations [1] , was significantly higher in France than in Turkey. On the other hand, the presence of microbiology laboratories in Turkish ID wards was more common than in the French ID wards. The probable reason for this was that the ID specialization was established on internal medicine training followed by ID fellowship in France [2] , while Turkish specialists have a training based on integrated clinical microbiology and ID [3] . Although a central microbiology laboratory existed inside the hospitals, Turkish ID physicians preferred to perform basic and rapid tests like stains, direct microscopy, and agglutination tests in their own laboratories to prevent delays. Surveillance, prevention, and control of infections are core activities for the ID specialists [4] . The presence of IC committees, IC nurses and their qualifications, and surveillance types performed were comparable and in accordance with the current recommendations in both France and Turkey. The only difference was that invasive device-associated surveillance, which reflects the most critical changes in hospital epidemiology and provides comparisons between the institutions [5] , was performed more commonly in Turkish hospitals. This could be related to the strict regulations to survey nosocomial infections compared to the yearly evaluation in French hospitals. On the other hand, parameters related to hand hygiene, the core activity for IC control [6] , the availability of personal protective equipment and their easy access, daily cleaning procedures, one of the key points in reducing hospitalacquired infections [7] , and separation of wastes during disposal were quite reasonable in both France and Turkey. The surveillance of HCWs for vaccination, which safeguards the personnel and protects patients from being infected through infected workers [8] , was significantly higher in Turkish hospitals. However, the poor efficacy of this strategy has long been debated in Turkey [9] . Likewise, HCWs' vaccination monitoring is reported not to be organized satisfactorily in France, except the mandatory hepatitis B virus (HBV) immunization campaign. As an example, the flu vaccination rate was reported to be less than 30 % in Thus, HCWs are believed to be undervaccinated in both countries. The sources of infections and the types of infections were quite similar in both countries. However, French ID specialists followed bone and joint infections, pneumonia, sepsis with unknown etiology, HIV infection, and infective endocarditis, while Turkish clinicians treated diabetic foot infections, skin and soft tissue infections, urinary tract infections, brucellosis, viral hepatitis, and CCHF more frequently. For the Turkish side, CCHF and brucellosis are endemic and problematic issues in Turkey [10] . France is officially free of endogenous brucellosis, and recent CCHF outbreaks in Turkey and the Balkans demonstrated the transmission into the European area [11] . On the other hand, HIV infection is already known to be much more prevalent in France (http://www.avert.org/ european-hiv-aids-statistics.htm), but, surprisingly, not hepatitis B or C. In contrast, Turkish ID specialists treat chronic viral hepatitis cases according to the legal regulations for reimbursement and are quite active on this issue. However, the differences in aforementioned diagnoses were probably related to patient flow or due to the mutual concepts with other disciplines in patient sharing in both countries. Incidences of diseases, access to treatment, and cultural behaviors for hospitalizing patients may be other possible explanations. Antibiotic use varies according to time and treatment locations [12] . In this study, the ratio of patients receiving antibiotics in the ID wards in both countries did not differ significantly. However, Turkish ID physicians prescribed a broad spectrum of antibiotics more frequently compared to French specialists. Anti-Gram-positive agents, carbapenems, and tigecycline were used significantly more often in Turkish ID wards. According to a nationwide survey, broad-spectrum antibiotic use was an issue of concern in the management of infections in ICUs in Turkey [13] . However, a relatively narrow spectrum of drugs like cephalosporins, penicillins, aminoglycosides, and metronidazole was more frequently preferred in France. The most likely reason for this difference may be the predomination of multiple and extensively resistant pathogens like Acinetobacter species, extended-spectrum beta-lactamase (ESBL)-positive enteric pathogens, and Pseudomonas aeruginosa in Turkish hospitals [10] . The current trend in medical practice in Turkey is that, while Staphylococcus aureus disappears from Turkish hospitals, Acinetobacter replaces it [14] [15] [16] . When the infecting bacteria were taken into consideration, streptococci were more frequent in France and enteric Gram-negatives in Turkey. Although the rates of ESBL-producing Gram-negative bacteria were less than 5 % in community-acquired infections, and less than 15 % in nosocomial infections in France (http:// www.onerba.org/IMG/pdf/ONERBA_rap2009-10_CH6_ sommaire.pdf), the rates of ESBL-producers in the hospitals were exceedingly high in Turkey [10] . Consequently, the resistance issue may contribute to the use of carbapenems in Turkish hospitals. Our findings correlate with another French report on antibiotic use in France with less carbapenems and more cephalosporins, penicillins, and aminoglycosides [17] . However, the frequent use of anti-Gram-positive agents may not be directly related to the requirement of these antibiotics in Turkey. One aspect of our data which supports this point of view was the rate of identifying the infecting agent by culture, and subsequent treatment due to microbiological data appears to be lower in Turkey than it is in France. Consequently, Turkish ID physicians use antibiotics on an empirical basis more frequently and, thus, this style may limit the deescalation of a broad spectrum of antibiotics. Other than that, Turkey is a restructuring country and evolving legal procedures on malpractice issues are strictly enforcing clinicians for possible liability, which may facilitate the use of a broad spectrum of antibiotics.
The major limitation of this study was that the results were merely declarative, based on voluntary participation. In conclusion, both France and Turkey have established their ID departments according to their fundamental needs and historical evolutions. Today, the ID departments in both countries have common and different characteristics. Although Turkish ID departments have greater access to an internal laboratory, they less frequently document the infecting pathogens and the discrepancies in antibiotic use between both countries are striking. These differences may, indeed, be related to differences in the epidemiology of resistance and the diagnostic differences. But for many other parameters related to anti-infective management in the ID wards in France and Turkey, both countries manage the routine medical work in a satisfactory and similar fashion.
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